Literature DB >> 10518276

Transcobalamin II deficiency with methylmalonic aciduria in three sisters.

H Bibi1, Z Gelman-Kohan, E R Baumgartner, D S Rosenblatt.   

Abstract

Transcobalamin II (TC II) is a plasma protein that binds vitamin B12 (cobalamin, Cbl) and facilitates cellular Cbl uptake by receptor-mediated endocytosis. In autosomal recessive TC II deficiency, intracellular Cbl deficiency results in an early onset of megaloblastic anaemia that may be accompanied by neurological abnormalities. Inadequate treatment may lead to neurological abnormalities. We describe three sisters, the daughters of first cousins of Moroccan origin, with TC II deficiency requiring continuous and long-term vitamin B12 treatment. The diagnosis was suspected from the finding of low unsaturated vitamin B12 binding capacity and confirmed by absence of detectable TC II by radioimmunoassay and by inability of cultured fibroblasts to synthesize TC II.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518276     DOI: 10.1023/a:1005507204491

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  23 in total

1.  Fractionation of serum transcobalamins on charged cellulose filters.

Authors:  J Selhub; B Rachmilewitz; N Grossowicz
Journal:  Proc Soc Exp Biol Med       Date:  1976-06

Review 2.  Transcobalamin II deficiency: case report and review of the literature.

Authors:  Y Kaikov; L D Wadsworth; C A Hall; P C Rogers
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

3.  Hereditary transcobalamin II deficiency: clinical findings in a new family.

Authors:  W H Hitzig; U Dohmann; H J Pluss; D Vischer
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

4.  Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings.

Authors:  N Hakami; P E Neiman; G P Canellos; J Lazerson
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  Congenital transcobalamin II deficiency presenting atypically with a low serum cobalamin level: studies demonstrating the coexistence of a circulating transcobalamin I (R binder) complex.

Authors:  R Carmel; Y Ravindranath
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

6.  The neurologic aspects of transcobalamin II deficiency.

Authors:  C A Hall
Journal:  Br J Haematol       Date:  1992-01       Impact factor: 6.998

7.  Transcobalamins I and II as natural transport proteins of vitamin B12.

Authors:  C A Hall
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

Review 8.  Transcobalamin II and the membrane receptor for the transcobalamin II-cobalamin complex.

Authors:  S P Rothenberg; E V Quadros
Journal:  Baillieres Clin Haematol       Date:  1995-09

9.  Altered vitamin B12 metabolism in fibroblasts from a patient with megaloblastic anemia and homocystinuria due to a new defect in methionine biosynthesis.

Authors:  D S Rosenblatt; B A Cooper; A Pottier; H Lue-Shing; N Matiaszuk; K Grauer
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Inherited lack of transcobalamin II in serum and megaloblastic anaemia: a further patient.

Authors:  J F Burman; D L Mollin; N A Sourial; R A Sladden
Journal:  Br J Haematol       Date:  1979-09       Impact factor: 6.998

View more
  2 in total

1.  Transcobalamin (TC) deficiency--potential cause of bone marrow failure in childhood.

Authors:  C Prasad; D S Rosenblatt; K Corley; A E L Cairney; C A Rupar
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

2.  Update on transcobalamin deficiency: clinical presentation, treatment and outcome.

Authors:  Y J Trakadis; A Alfares; O A Bodamer; M Buyukavci; J Christodoulou; P Connor; E Glamuzina; F Gonzalez-Fernandez; H Bibi; B Echenne; I Manoli; J Mitchell; M Nordwall; C Prasad; F Scaglia; M Schiff; B Schrewe; G Touati; M C Tchan; B Varet; C P Venditti; D Zafeiriou; C A Rupar; D S Rosenblatt; D Watkins; N Braverman
Journal:  J Inherit Metab Dis       Date:  2013-12-05       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.